First Comprehensive Gene Map of the Human Brain Developed
|
By LabMedica International staff writers Posted on 26 Apr 2011 |
A new human brain atlas reveals more than 90% similarity among humans, and details genes at work throughout the brain to further scientific research and medical outcomes.
The Allen Institute for Brain Science (Seattle, WA, USA) has released the world's first anatomically and genomically comprehensive human brain map, a previously improbable endeavor made possible through leading-edge technology and more than four years of demanding studies and documentation. The mappings are the foundation for the Allen Human Brain Atlas, an online public resource developed to advance the Institute's goal to accelerate understanding of how the human brain works and fuel new discovery among the global research community.
In developing the Allen Human Brain Atlas, the Allen Institute has now characterized and mapped the biochemistry of two normal adult human brains, providing opportunities for scientists to study the brain with new detail and accuracy. The data reveal a remarkable 94% similarity between human brains, establishing strong patterns as a critical foundation for translational and clinical research. Moreover, data analysis from the two human brains indicate that at least 82% of all human genes are expressed in the brain, highlighting its great complexity while also providing an essential genetic blueprint to understand brain functionality better and fuel research in neurologic disease and other brain disorders.
"Until now, a definitive map of the human brain, at this level of detail, simply hasn't existed,” said Allan Jones, PhD, chief executive officer of the Allen Institute for Brain Science. "The Allen Human Brain Atlas provides never-before-seen views into our most complex and most important organ. Understanding how our genes are used in our brains will help scientists and the medical community better understand and discover new treatments for the full spectrum of brain diseases and disorders, from mental illness and drug addiction, to Alzheimer's and Parkinson's diseases, multiple sclerosis, autism, and more.”
Similar to a high-powered, multifunctional GPS (global positioning system) navigation system, the Allen Human Brain Atlas identifies 1,000 anatomic sites in the human brain, underscored by more than 100 million data points that indicate the particular gene expression and underlying biochemistry of each site. Scientists can utilize the Allen Human Brain Atlas to explore the human brain and identify how disease and trauma, including physical brain injuries and mental health disorders, affect specific areas of the brain. This resource makes it possible to pinpoint where a particular drug acts anatomically in the brain, to ultimately better control the successful outcome of numerous therapies.
"The Allen Institute is a powerful force in modern science,” said Dr. Edward Jones, neuroscientist at the University of California, Davis. "They've applied an industrialized approach and high-output technology to accomplish what no other lab has ever done. The original data produced for the mouse brain revolutionized neuroscience and now the Allen Human Brain Atlas delivers extremely rare and essential information that most researchers could not otherwise access. They are truly paving the way for the future of research."
The Allen Human Brain Atlas is free and available to scientists, physicians, and the education community as an online public resource (please see Related Links below).
Previously, as its inaugural initiative, the Allen Institute for Brain Science completed mappings of the adult mouse brain in 2006, similarly making the data available free to scientists. Overall, those data have led to a number of significant research advances worldwide, including the publishing of over 500 peer-reviewed papers citing the Allen Mouse Brain Atlas to support research conclusions.
A significant feature of the Atlas that makes it a powerful research tool is that it fully integrates several different kinds of data across different scales of brain exploration. Data incorporated into the Atlas include magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), as well as histology and gene expression data derived from both microarray and in-situ hybridization (ISH) approaches.
Users of the Allen Human Brain Atlas comprise a diverse range of biomedical researchers--primarily neuroscientists--throughout the world. They include scientists who study the human brain itself, as well as those working in mouse and other model systems, providing a rare and important opportunity for them to probe the relevance of the findings to humans. Some 4,000 unique visitors are now accessing the new Atlas each month.
It is anticipated that the Allen Human Brain Atlas will be used in small and large-scale applications to examine diseases and disorders, such as obesity, Parkinson's disease, autism, schizophrenia, Alzheimer's disease, and multiple sclerosis--as well as those exploring how the healthy brain works.
The Allen Institute for Brain Science will continue to expand the Allen Human Brain Atlas in the coming years, with new data from additional brains, as well as enhanced tools for searching, analyzing, and viewing the data.
The Allen Institute for Brain Science is a medical research organization focused on accelerating understanding of the human brain by driving discovery for the broader scientific community.
Related Links:
Allen Institute for Brain Science
Allen Human Brain Atlas
The Allen Institute for Brain Science (Seattle, WA, USA) has released the world's first anatomically and genomically comprehensive human brain map, a previously improbable endeavor made possible through leading-edge technology and more than four years of demanding studies and documentation. The mappings are the foundation for the Allen Human Brain Atlas, an online public resource developed to advance the Institute's goal to accelerate understanding of how the human brain works and fuel new discovery among the global research community.
In developing the Allen Human Brain Atlas, the Allen Institute has now characterized and mapped the biochemistry of two normal adult human brains, providing opportunities for scientists to study the brain with new detail and accuracy. The data reveal a remarkable 94% similarity between human brains, establishing strong patterns as a critical foundation for translational and clinical research. Moreover, data analysis from the two human brains indicate that at least 82% of all human genes are expressed in the brain, highlighting its great complexity while also providing an essential genetic blueprint to understand brain functionality better and fuel research in neurologic disease and other brain disorders.
"Until now, a definitive map of the human brain, at this level of detail, simply hasn't existed,” said Allan Jones, PhD, chief executive officer of the Allen Institute for Brain Science. "The Allen Human Brain Atlas provides never-before-seen views into our most complex and most important organ. Understanding how our genes are used in our brains will help scientists and the medical community better understand and discover new treatments for the full spectrum of brain diseases and disorders, from mental illness and drug addiction, to Alzheimer's and Parkinson's diseases, multiple sclerosis, autism, and more.”
Similar to a high-powered, multifunctional GPS (global positioning system) navigation system, the Allen Human Brain Atlas identifies 1,000 anatomic sites in the human brain, underscored by more than 100 million data points that indicate the particular gene expression and underlying biochemistry of each site. Scientists can utilize the Allen Human Brain Atlas to explore the human brain and identify how disease and trauma, including physical brain injuries and mental health disorders, affect specific areas of the brain. This resource makes it possible to pinpoint where a particular drug acts anatomically in the brain, to ultimately better control the successful outcome of numerous therapies.
"The Allen Institute is a powerful force in modern science,” said Dr. Edward Jones, neuroscientist at the University of California, Davis. "They've applied an industrialized approach and high-output technology to accomplish what no other lab has ever done. The original data produced for the mouse brain revolutionized neuroscience and now the Allen Human Brain Atlas delivers extremely rare and essential information that most researchers could not otherwise access. They are truly paving the way for the future of research."
The Allen Human Brain Atlas is free and available to scientists, physicians, and the education community as an online public resource (please see Related Links below).
Previously, as its inaugural initiative, the Allen Institute for Brain Science completed mappings of the adult mouse brain in 2006, similarly making the data available free to scientists. Overall, those data have led to a number of significant research advances worldwide, including the publishing of over 500 peer-reviewed papers citing the Allen Mouse Brain Atlas to support research conclusions.
A significant feature of the Atlas that makes it a powerful research tool is that it fully integrates several different kinds of data across different scales of brain exploration. Data incorporated into the Atlas include magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), as well as histology and gene expression data derived from both microarray and in-situ hybridization (ISH) approaches.
Users of the Allen Human Brain Atlas comprise a diverse range of biomedical researchers--primarily neuroscientists--throughout the world. They include scientists who study the human brain itself, as well as those working in mouse and other model systems, providing a rare and important opportunity for them to probe the relevance of the findings to humans. Some 4,000 unique visitors are now accessing the new Atlas each month.
It is anticipated that the Allen Human Brain Atlas will be used in small and large-scale applications to examine diseases and disorders, such as obesity, Parkinson's disease, autism, schizophrenia, Alzheimer's disease, and multiple sclerosis--as well as those exploring how the healthy brain works.
The Allen Institute for Brain Science will continue to expand the Allen Human Brain Atlas in the coming years, with new data from additional brains, as well as enhanced tools for searching, analyzing, and viewing the data.
The Allen Institute for Brain Science is a medical research organization focused on accelerating understanding of the human brain by driving discovery for the broader scientific community.
Related Links:
Allen Institute for Brain Science
Allen Human Brain Atlas
Latest BioResearch News
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
Channels
Clinical Chemistry
view channel
New Plasma Tau Assay Improves Prediction of Alzheimer’s Progression
Predicting which patients with early symptomatic Alzheimer’s disease will decline more rapidly remains a key challenge in both research and patient care. Growing interest in tau biology, along with advances... Read more
Routine Blood Markers Predict Heart Failure Risk in Prediabetes
Heart failure prevention relies on finding high-risk adults before symptoms appear, yet effective stratification remains difficult in routine care. Prediabetes affects an estimated 115.2 million U.... Read moreMolecular Diagnostics
view channel
Blood Biomarker Predicts Cognitive Outcomes After Cardiac Arrest
Long-term cognitive impairment is a frequent consequence of out-of-hospital cardiac arrest yet early prediction remains difficult. Clinicians commonly use blood-based markers to estimate brain injury risk... Read more
Liquid Biopsy Enables Faster Diagnosis of Childhood Cancer in Africa
Burkitt lymphoma is the most common childhood cancer in Africa and progresses rapidly, making fast, accurate diagnosis essential to survival. Although survival can exceed 90% when therapy starts quickly,... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read more
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read more
New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read moreTechnology
view channel
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read more
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
Treatment selection for metastatic colorectal cancer often requires knowledge of a tumor’s microsatellite instability (MSI) status. Timely results can help clinicians decide on immunotherapy options.... Read more








